Evaluating lung function improvement after bronchial thermoplasty in severe asthma patients
Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma
This study looks at how bronchial thermoplasty affects lung function in people with severe asthma by checking their breathing tests before and after the treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | University of Oklahoma Academic / other |
| Locations | 1 site (Oklahoma City, Oklahoma) |
| Trial ID | NCT02241265 on ClinicalTrials.gov |
What this trial studies
This observational study aims to retrospectively analyze spirometry data from patients with severe asthma who have undergone bronchial thermoplasty. The researchers will review medical records from two centers, focusing on changes in forced expiratory volume (FEV1) before and after the thermoplasty procedure, which is performed in three sessions. The study will collect comprehensive data, including demographics and spirometric results, to assess the effectiveness of the treatment.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old diagnosed with severe asthma and experiencing decreased FEV1.
Not a fit: Patients under 18 years of age will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the effectiveness of bronchial thermoplasty in improving lung function for patients with severe asthma.
How similar studies have performed: Previous studies have shown promising results for bronchial thermoplasty in asthma management, indicating that this approach has been tested with some success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * \>18 years of age * severe asthma diagnosis * decreased FEV1 Exclusion Criteria: * \< 18 years of age
Where this trial is running
Oklahoma City, Oklahoma
- Ouhsc — Oklahoma City, Oklahoma, United States (Recruiting)
Study contacts
- Principal investigator: Brent Brown, MD — Ouhsc
- Study coordinator: Brent Brown, MD
- Email: brent-brown@ouhsc.edu
- Phone: 405-271-6173
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.